| Title |
Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris - Volume 23, Number 2—February 2017 - Emerging Infectious Diseases journal - CDC
|
|---|---|
| Published in |
Emerging Infectious Diseases, February 2017
|
| DOI | 10.3201/eid2302.161320 |
| Pubmed ID | |
| Authors |
Leighann Sherry, Gordon Ramage, Ryan Kean, Andrew Borman, Elizabeth M. Johnson, Malcolm D. Richardson, Riina Rautemaa-Richardson |
| Abstract |
The emerging multidrug-resistant yeast pathogen Candida auris has attracted considerable attention as a source of healthcare-associated infections. We report that this highly virulent yeast has the capacity to form antifungal resistant biofilms sensitive to the disinfectant chlorhexidine in vitro. |
X Demographics
The data shown below were collected from the profiles of 34 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 10 | 29% |
| South Africa | 4 | 12% |
| Canada | 2 | 6% |
| Antigua and Barbuda | 1 | 3% |
| United States | 1 | 3% |
| Spain | 1 | 3% |
| Unknown | 15 | 44% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 16 | 47% |
| Scientists | 10 | 29% |
| Practitioners (doctors, other healthcare professionals) | 8 | 24% |
Mendeley readers
The data shown below were compiled from readership statistics for 349 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | <1% |
| Colombia | 1 | <1% |
| Unknown | 347 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 53 | 15% |
| Student > Bachelor | 53 | 15% |
| Student > Master | 43 | 12% |
| Researcher | 39 | 11% |
| Student > Postgraduate | 15 | 4% |
| Other | 51 | 15% |
| Unknown | 95 | 27% |
| Readers by discipline | Count | As % |
|---|---|---|
| Immunology and Microbiology | 61 | 17% |
| Biochemistry, Genetics and Molecular Biology | 52 | 15% |
| Agricultural and Biological Sciences | 41 | 12% |
| Medicine and Dentistry | 36 | 10% |
| Chemistry | 11 | 3% |
| Other | 41 | 12% |
| Unknown | 107 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 464. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 January 2021.
All research outputs
#59,552
of 26,017,215 outputs
Outputs from Emerging Infectious Diseases
#149
of 9,860 outputs
Outputs of similar age
#1,377
of 431,660 outputs
Outputs of similar age from Emerging Infectious Diseases
#4
of 132 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 9,860 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 46.1. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 431,660 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 132 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.